Sec. 1. Short title; table of contents

422 words·~2 min read·/bill/115/s/2680/rs/section-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the . Opioid Crisis Response Act of 2018 The table of contents of this Act is as follows: Sec. 1. Short title; table of contents. TITLE I—Reauthorization of Cures funding Sec. 101. State response to the opioid abuse crisis. TITLE II—Research and innovation Sec. 201. Advancing cutting-edge research. Sec. 202. Pain research. TITLE III—Medical Products and Controlled Substances Safety Sec. 301. Clarifying FDA regulation of non-addictive pain products. Sec. 302.

Clarifying FDA packaging authorities. Sec. 303. Strengthening FDA and CBP coordination and capacity. Sec. 304. Clarifying FDA post-market authorities. Sec. 305. First responder training. Sec. 306. Disposal of controlled substances of a deceased hospice patient by employees of a hospice program. Sec. 307. GAO study and report on hospice safe drug management. Sec. 308. Delivery of a controlled substance by a pharmacy to be administered by injection, implantation, or intrathecal pump.

TITLE IV—Treatment and recovery Sec. 401. Comprehensive opioid recovery centers. Sec. 402. Program to support coordination and continuation of care for drug overdose patients. Sec. 403. Alternatives to opioids. Sec. 404. Peer support technical assistance. Sec. 405. Medication-assisted treatment for recovery from addiction. Sec. 406. National recovery housing best practices. Sec. 407. Addressing economic and workforce impacts of the opioid crisis. Sec. 408. Youth prevention and recovery.

Sec. 409. Plans of safe care. Sec. 410. Regulations relating to special registration for telemedicine. Sec. 411. National Health Service Corps behavioral and mental health professionals providing obligated service in schools and other community-based settings. Sec. 412. Loan repayment for substance use disorder treatment providers. Sec. 413. Improving treatment for pregnant and postpartum women. Sec. 414. Early interventions for pregnant women and infants. TITLE V—Prevention Sec. 501.

Study on prescribing limits. Sec. 502. Programs for health care workforce. Sec. 503. Education and awareness campaigns. Sec. 504. Enhanced controlled substance overdoses data collection, analysis, and dissemination. Sec. 505. Preventing overdoses of controlled substances. Sec. 506. CDC surveillance and data collection for child, youth, and adult trauma. Sec. 507. Reauthorization of NASPER. Sec. 508. Jessie’s Law. Sec. 509. Development and dissemination of model training programs for substance use disorder patient records.

Sec. 510. Communication with families during emergencies. Sec. 511. Prenatal and postnatal health. Sec. 512. Surveillance and education regarding infections associated with injection drug use and other risk factors. Sec. 513. Task force to develop best practices for trauma-informed identification, referral, and support. Sec. 514. Grants to improve trauma support services and mental health care for children and youth in educational settings. Sec. 515. National Child Traumatic Stress Initiative.